MENU
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more

A.I. Advisor
published Earnings

TBPH is expected to report earnings to rise 772.00% to 61 cents per share on March 02

Theravance Biopharma TBPH Stock Earnings Reports
Q4'25
Est.
$0.61
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.41
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.11
The last earnings report on November 10 showed earnings per share of 7 cents, beating the estimate of -12 cents. With 817.91K shares outstanding, the current market capitalization sits at 908.56M.
View a ticker or compare two or three
TBPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TBPH showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com